Johnson & Johnson has been fighting thousands of lawsuits over its now-discontinued talc products for 16 years. A pending ...

That includes a roughly $2 billion award in favor of 22 women who blamed their ovarian ... lawsuits relate to a rare cancer called mesothelioma and will be addressed outside of the new settlement ...

The deal would allow it to resolve the lawsuits through a third ... in hopes of reaching consensus on a settlement of all current and future ovarian cancer claims. Ovarian cancer claims account ...

Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby powder caused ovarian cancer, as it tries to convince a judge to sign off on ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

J&J is attempting to use a subsidiary’s bankruptcy to resolve lawsuits from more ... J&J is trying to force women with ovarian cancer to accept lower settlement payments based on a deeply ...

Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.

The settlement deal aims to resolve lawsuits alleging that Johnson and Johnson's "baby powder" products cause ovarian cancer. Johnson & Johnson deny all claims. Johnson & Johnson is offering to ...

NEW YORK (Reuters) -Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby powder caused ovarian cancer, as it tries to convince ...

Johnson & Johnson faces a critical test on Tuesday over its $10 billion proposal to end litigation alleging that its baby powder caused ovarian cancer, as it tries to convince a judge to sign off on ...